Trial comparisons

curl "https://conductscience.org/api/comparisons/v1?page=233"

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=233

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT00796445-9e3268a9",
        "title": "MAGE-A3 Group vs Placebo Group: Number of Subjects With Any Adverse Events (AEs)",
        "summary": "822 of 895 against 333 of 450; risk difference 17.8 points, 95% interval 13.5 to 22.4; NCT00796445, A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their Tumor",
        "record": "/library/comparisons/NCT00796445-9e3268a9",
        "nct_id": "NCT00796445",
        "kind": "outcome",
        "participants": 1345,
        "risk_difference": {
          "value": 0.17843575418994417,
          "lower": 0.13526759402201405,
          "upper": 0.22385811663292526
        },
        "group_1": "822 of 895",
        "group_2": "333 of 450",
        "difference": "17.8 points",
        "interval": "13.5 to 22.4",
        "trial_title": "A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their Tumor"
      },
      {
        "id": "NCT00796445-deaths",
        "title": "MAGE-A3 Group vs Placebo Group: deaths from any cause",
        "summary": "5 of 895 against 1 of 450; risk difference 0.3 points, 95% interval -0.7 to 1.1; NCT00796445, A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their Tumor",
        "record": "/library/comparisons/NCT00796445-deaths",
        "nct_id": "NCT00796445",
        "kind": "deaths",
        "participants": 1345,
        "risk_difference": {
          "value": 0.0033643699565487277,
          "lower": -0.007379188087918093,
          "upper": 0.01101062909852062
        },
        "group_1": "5 of 895",
        "group_2": "1 of 450",
        "difference": "0.3 points",
        "interval": "-0.7 to 1.1",
        "trial_title": "A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their Tumor"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "No license stated"
    }
  ],
  "next": "/api/comparisons/v1?page=234",
  "request_id": "8X6XQvzV-FPCjPgF"
}